The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Functions of Galectin-3 and Its Role in Fibrotic Diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Extracellular Matrix: Not Just Pretty Fibrils
Hynes, R. O. (2009) · Science · doi:10.1126/science.1176009 · Cited by 3,527
Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis
Gumbiner, B. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81279-9 · Cited by 3,471
Nathan, C., & Ding, A. (2010) · Cell · doi:10.1016/j.cell.2010.02.029 · Cited by 2,183
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Wynn, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31487 · Cited by 1,456
Cellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., & Chapman, H. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605669103 · Cited by 1,257
Sharma, U. C., Pokharel, S., van Brakel, T. J., van Berlo, J. H., Cleutjens, J. P. M., Schroen, B., André, S., Crijns, H. J. G. M., Gabius, H. J., Maessen, J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000147181.65298.4d · Cited by 947
Galectins: structure, function and therapeutic potential
Yang, R.-Y., Rabinovich, G. A., & Liu, F.-T. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000719 · Cited by 862
Aplin, A. E., Howe, A., Alahari, S. K., & Juliano, R. L. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01359-0 · Cited by 847
Expression of galectin-3 modulates T-cell growth and apoptosis.
Yang, R. Y., Hsu, D. K., & Liu, F. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6737 · Cited by 789
Regulation of PDGF and its receptors in fibrotic diseases
Bonner, J. C. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.006 · Cited by 768
Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis
Partridge, E. A., Le Roy, C., Di Guglielmo, G. M., Pawling, J., Cheung, P., Granovsky, M., Nabi, I. R., Wrana, J. L., & Dennis, J. W. (2004) · Science · doi:10.1126/science.1102109 · Cited by 735
Therapy for Fibrotic Diseases: Nearing the Starting Line
Friedman, S. L., Sheppard, D., Duffield, J. S., & Violette, S. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004700 · Cited by 655
Wollin, L., Maillet, I., Quesniaux, V., Holweg, A., & Ryffel, B. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208223 · Cited by 633
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Poirier, F., Russo, F. P., Iredale, J. P., Haslett, C., Simpson, K. J., & Sethi, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511167103 · Cited by 625
Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
Ho, J. E., Liu, C., Lyass, A., Courchesne, P., Pencina, M. J., Vasan, R. S., Larson, M. G., & Levy, D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.053 · Cited by 589
Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Kipari, T., Haslett, C., Iredale, J. P., Liu, F.-T., Hughes, J., & Sethi, T. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070726 · Cited by 562 · cited 11×
“Recent evidence suggests that Gal-3 plays a key role in the development of fibrosis in liver, blood vessels, kidney, heart, and lung (Nishi et al., 2007; Henderson et al., 2008; Ho et al., 2012; Jiang et al., 2012; Calvier et al., 2013) (Fig.”
BackgroundInfluentialRegulation of Alternative Macrophage Activation by Galectin-3
MacKinnon, A. C., Farnworth, S. L., Hodkinson, P. S., Henderson, N. C., Atkinson, K. M., Leffler, H., Nilsson, U. J., Haslett, C., Forbes, S. J., & Sethi, T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2650 · Cited by 543
Human Galectin-3 Is a Novel Chemoattractant for Monocytes and Macrophages
Sano, H., Hsu, D. K., Yu, L., Apgar, J. R., Kuwabara, I., Yamanaka, T., Hirashima, M., & Liu, F.-T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2156 · Cited by 521
Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
MacKinnon, A. C., Gibbons, M. A., Farnworth, S. L., Leffler, H., Nilsson, U. J., Delaine, T., Simpson, A. J., Forbes, S. J., Hirani, N., Gauldie, J., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201106-0965oc · Cited by 516
Galectin-3 and Galectin-1 Bind Distinct Cell Surface Glycoprotein Receptors to Induce T Cell Death
Stillman, B. N., Hsu, D. K., Pang, M., Brewer, C. F., Johnson, P., Liu, F.-T., & Baum, L. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.778 · Cited by 507
Lok, D. J. A., Van Der Meer, P., de la Porte, P. W. B.-A., Lipsic, E., Van Wijngaarden, J., Hillege, H. L., & van Veldhuisen, D. J. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0125-y · Cited by 465
Galectin-3 Induces Endothelial Cell Morphogenesis and Angiogenesis
Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S., Hogan, V., Pienta, K. J., & Raz, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64959-0 · Cited by 446
Yu, L., Ruifrok, W. P. T., Meissner, M., Bos, E. M., van Goor, H., Sanjabi, B., van der Harst, P., Pitt, B., Goldstein, I. J., Koerts, J. A., et al. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.971168 · Cited by 435
Molecular and cellular mechanisms of pulmonary fibrosis
Todd, N. W., Luzina, I. G., & Atamas, S. P. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-11 · Cited by 418
Galectin-3 : a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family
赤埴, 詩. (2000) · doi:10.11501/3172767 · Cited by 387
Extracellular functions of galectin-3
Ochieng, J., Furtak, V., & Lukyanov, P. (2002) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000014082.99675.2f · Cited by 370
CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis.
Fukumori, T., Takenaka, Y., Yoshii, T., Kim, H.-R. C., Hogan, V. A., Inohara, H., Kagawa, S., & Raz, A. (2003) · PubMed · Cited by 364
Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis
Calvier, L., Miana, M., Reboul, P., Cachofeiro, V., Martinez-Martinez, E., de Boer, R. A., Poirier, F., Lacolley, P., Zannad, F., Rossignol, P., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300569 · Cited by 359
Fuchs, B. C., Hoshida, Y., Fujii, T., Wei, L., Yamada, S., Lauwers, G. Y., McGinn, C. M., DePeralta, D. K., Chen, X., Kuroda, T., et al. (2014) · Hepatology · doi:10.1002/hep.26898 · Cited by 351
Hepatic inflammation and progressive liver fibrosis in chronic liver disease
Czaja, A. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2515 · Cited by 342
Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family.
Akahani, S., Nangia‐Makker, P., Inohara, H., Kim, H. R., & Raz, A. (1997) · PubMed · Cited by 339
Cellular and molecular mechanisms of intestinal fibrosis
Speca, S. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i28.3635 · Cited by 272
Sato, S., & Hughes, R. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50525-7 · Cited by 270
Liu, Y.-H., D'Ambrosio, M., Liao, T.-D., Peng, H., Rhaleb, N.-E., Sharma, U., André, S., Gabius, H.-J., & Carretero, O. A. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00747.2008 · Cited by 269
Bayes-Genis, A., de Antonio, M., Vila, J., Peñafiel, J., Galán, A., Barallat, J., Zamora, E., Urrutia, A., & Lupón, J. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.087 · Cited by 259
Sato, S., & Hughes, R. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41797-2 · Cited by 246
Role of Galectin-3 in Human Pulmonary Fibrosis
Nishi, Y., Sano, H., Kawashima, T., Okada, T., Kuroda, T., Kikkawa, K., Kawashima, S., Tanabe, M., Goto, T., Matsuzawa, Y., et al. (2007) · Allergology International · doi:10.2332/allergolint.o-06-449 · Cited by 226
Lopez-Andrès, N., Rossignol, P., Iraqi, W., Fay, R., Nuée, J., Ghio, S., Cleland, J. G. F., Zannad, F., & Lacolley, P. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr151 · Cited by 225
Traber, P. G., Chou, H., Zomer, E., Hong, F., Klyosov, A., Fiel, M.-I., & Friedman, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075361 · Cited by 214
Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis
Mallat, A., & Lotersztajn, S. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00230.2013 · Cited by 211
Potential approaches to reverse or repair renal fibrosis
Tampe, D., & Zeisberg, M. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.14 · Cited by 195
Zuberi, R. I., Hsu, D. K., Kalayci, O., Chen, H.-Y., Sheldon, H. K., Yu, L., Apgar, J. R., Kawakami, T., Lilly, C. M., & Liu, F.-T. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63255-5 · Cited by 184
Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance
Kikuchi, N., Ishii, Y., Morishima, Y., Yageta, Y., Haraguchi, N., Itoh, K., Yamamoto, M., & Hizawa, N. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-31 · Cited by 176
cAMP and Epac in the regulation of tissue fibrosis
Insel, P. A., Murray, F., Yokoyama, U., Romano, S., Yun, H., Brown, L., Snead, A., Lu, D., & Aroonsakool, N. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01847.x · Cited by 175 · cited 1×
“…Tissue fibrosis is a progressive, severely debilitating disease characterized by superabundant accumulation of extracellular matrix (ECM) leading to excessive tissue scarring, organ injury, function decline, and even failure (Insel et al., 2012; Speca et al., 2012; Friedman et al., 2013).”
BackgroundInohara, H., & Raz, A. (1994) · Glycoconjugate Journal · doi:10.1007/bf00731303 · Cited by 172
Vascular fibrosis in atherosclerosis
Lan, T.-H., Huang, X.-Q., & Tan, H.-M. (2013) · Cardiovascular Pathology · doi:10.1016/j.carpath.2013.01.003 · Cited by 164
Endoplasmic Reticulum Stress Implicated in the Development of Renal Fibrosis
Chiang, C., Hsu, S. P., Wu, C.-T., Huang, J., Cheng, H., Chang, Y.-W., Hung, K., Wu, K.-D., & Liu, S. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00131 · Cited by 163
Maeda, N., Kawada, N., Seki, S., Arakawa, T., Ikeda, K., Iwao, H., Okuyama, H., Hirabayashi, J., Kasai, K., & Yoshizato, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209673200 · Cited by 161
He, X., Wang, L., Szklarz, G. D., Bi, Y., & Ma, Q. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194142 · Cited by 157
Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen)
Dong, S., & Hughes, R. C. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018554124545 · Cited by 150
Mac-2: a versatile galactose-binding protein of mammalian tissues
Hughes, R. C. (1994) · Glycobiology · doi:10.1093/glycob/4.1.5 · Cited by 136
Endogenous Galectin-3 Determines the Routing of CD95 Apoptotic Signaling Pathways
Fukumori, T., Takenaka, Y., Oka, N., Yoshii, T., Hogan, V. A., Inohara, H., Kanayama, H.-O., Kim, H.-R. C., & Raz, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0336 · Cited by 134
Galectin-3 interacts with naïve and primed neutrophils, inducing innate immune responses
Nieminen, J., St-Pierre, C., & Sato, S. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1204702 · Cited by 131
Hsu, D. K., Chernyavsky, A. I., Chen, H., Yu, L., Grando, S. A., & Liu, F. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.276 · Cited by 112
Mourad-Zeidan, A. A., Melnikova, V. O., Wang, H., Raz, A., & Bar‐Eli, M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080380 · Cited by 110
Sriramarao, P., Wang, Z., Zuberi, R. I., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7800 · Cited by 108
Increased galectin-3 expression and intra-epithelial neutrophils in small airways in severe COPD
Pilette, C., Colinet, B., Robert Kiss, A., André, S., Kaltner, H., Gabius, H., Delos, M., Vaerman, J., Decramer, M., & Sibille, Y. (2007) · European Respiratory Journal · doi:10.1183/09031936.00073005 · Cited by 105
Role of galectin-3 as a receptor for advanced glycosylation end products
Pricci, F., Leto, G., Amadio, L., Iacobini, C., Romeo, G. R., Cordone, S., Gradini, R., Barsotti, P., Liu, F., Mario, U. D., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07706.x · Cited by 104
Haak, A. J., Tsou, P.-S., Amin, M. A., Ruth, J. H., Campbell, P., Fox, D. A., Khanna, D., Larsen, S. D., & Neubig, R. R. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.213520 · Cited by 103
Okamura, D. M., Pasichnyk, K., López-Guisa, J. M., Collins, S., Hsu, D. K., Liu, F., & Eddy, A. A. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00326.2010 · Cited by 103
Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo
Jiang, J. X., Chen, X., Hsu, D. K., Baghy, K., Serizawa, N., SCOTT, F. R., Takada, Y., Takada, Y. K., Fukada, H., Chen, J. Y., et al. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00257.2011 · Cited by 99
Li, L. I. U., Sakai, T., Sano, N., & Fukui, K. (2004) · Biochemical Journal · doi:10.1042/bj20031300 · Cited by 98
The Role of Galectin-3 in Promotion of the Inflammatory Response
Liu, F., & Hsu, D. K. (2007) · Drug News & Perspectives · doi:10.1358/dnp.2007.20.7.1149628 · Cited by 89
Kasper, M. E., & Hughes, R. C. (1996) · The Journal of Pathology · Cited by 76
Pera, T., Zuidhof, A. B., Smit, M., Menzen, M. H., Klein, T., Flik, G., Zaagsma, J., Meurs, H., & Maarsingh, H. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.210138 · Cited by 75
Dalton, P., Christian, H., Redman, C. W. G., Sargent, I. L., & Boyd, C. A. R. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05806.x · Cited by 72
Lung Inflammation and Fibrosis
Reynolds, H. Y. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-788pp · Cited by 71
Tubular Atrophy and Interstitial Fibrosis After Renal Transplantation Is Dependent on Galectin-3
Dang, Z., MacKinnon, A. C., Marson, L., & Sethi, T. (2012) · Transplantation · doi:10.1097/tp.0b013e318242f40a · Cited by 71
Taniguchi, T., Asano, Y., Akamata, K., Noda, S., Masui, Y., Yamada, D., Takahashi, T., Ichimura, Y., Toyama, T., Tamaki, Z., et al. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110755 · Cited by 70
Epigenetic Regulation of Galectin-3 Expression by β1 Integrins Promotes Cell Adhesion and Migration
Margadant, C., van den Bout, I., van Boxtel, A. L., Thijssen, V. L., & Sonnenberg, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.426445 · Cited by 63
Ma, B., Kang, Q., Li, Q., Cui, L., & Pei, C. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.068 · Cited by 62
Investigational drugs targeting cardiac fibrosis
Roubille, F., Busseuil, D., Merlet, N., Kritikou, E. A., Rhéaume, É., & Tardif, J. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.839942 · Cited by 60
Serum galectin-3 level in systemic sclerosis
Koca, S. S., Akbas, F., Özgen, M., Yolbaş, S., İlhan, N., Gündoğdu, B., & Işık, A. T. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2346-8 · Cited by 55
Dysregulation of Galectin-3. Implications for Hermansky-Pudlak Syndrome Pulmonary Fibrosis
Cullinane, A. R., Yeager, C., Dorward, H. M., Carmona‐Rivera, C., Wu, H. P., Moss, J., O’Brien, K., Nathan, S. D., Meyer, K. C., Rosas, I. O., et al. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0025oc · Cited by 52
Hao, C.-Q., Xie, Y.-M., Peng, M., Ma, L., Zhou, Y., Zhang, Y., Kang, W., Wang, J., Bai, X., Wang, P., et al. (2013) · Clinical and Experimental Medicine · doi:10.1007/s10238-013-0229-6 · Cited by 50
Cellular orchestrators of renal fibrosis
Conway, B. R., & Hughes, J. (2011) · QJM · doi:10.1093/qjmed/hcr235 · Cited by 46
Lee, Y., Lin, T., Chang, C., & Lo, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082478 · Cited by 44
Human Galectin-3 Selective and High Affinity Inhibitors. Present State and Future Perspectives
Téllez‐Sanz, R., García-Fuentes, L., & Vargas‐Berenguel, A. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990163 · Cited by 44
Karabıyık, H., Sevinçek, R., Petek, H., & Aygün, M. (2010) · Journal of Molecular Modeling · doi:10.1007/s00894-010-0832-3 · Cited by 41
Regulation of galectin‐3‐induced apoptosis of Jurkat cells by both O‐glycans and N‐glycans on CD45
Xue, J., Gao, X.-Q., Fu, C., Cong, Z., Jiang, H., Wang, W., Chen, T., Wei, Q., & Qin, C. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.10.034 · Cited by 41
Insulin‐like growth factor binding protein‐related protein 1 contributes to hepatic fibrogenesis
Guo, X. H., Liu, L. X., Zhang, H. Y., Zhang, Q. Q., Li, Y., Tian, X. X., & Qiu, Z. H. (2014) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12126 · Cited by 39 · cited 2×
“It appears to be widely accepted that investigating the targets that are aberrantly expressed in animal models and fibrotic patients promises to unearth new therapeutic strategies for fibrotic diseases.”
Backgroundde Oliveira, S. A., Souza, B. S. D. F., Barreto, E. P. D. S., Kaneto, C. M., Neto, H. A., Azevedo, C. M., Guimarães, E. T., de Freitas, L. A. R., Ribeiro‐dos‐Santos, R., & Soares, M. B. P. (2011) · Cytotherapy · doi:10.3109/14653249.2011.637668 · Cited by 34
Galectin-3 Enhances Epithelial Cell Adhesion and Wound Healing in Rat Cornea
Yabuta, C., Yano, F., Fujii, A., Shearer, T. R., & Azuma, M. (2013) · Ophthalmic Research · doi:10.1159/000355846 · Cited by 29
Polli, C. D., Toledo, K. A., Franco, L. H., Mariano, V. S., de Oliveira, L. L., Bernardes, E. S., Roque‐Barreira, M. C., & Pereira-da-Silva, G. (2013) · ISRN Inflammation · doi:10.1155/2013/259256 · Cited by 29
Relative Roles of TGF-βand IGFBP-5 in Idiopathic Pulmonary Fibrosis
Sureshbabu, A., Tonner, E., Allan, G. J., & Flint, D. J. (2011) · Pulmonary Medicine · doi:10.1155/2011/517687 · Cited by 25
Ameliorative Effect of Mepenzolate Bromide against Pulmonary Fibrosis
Kurotsu, S., Tanaka, K., Niino, T., Asano, T., Sugizaki, T., Azuma, A., Suzuki, H., & Mizushima, T. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.213009 · Cited by 16
Cited by
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G., Bellotti, C., Salehi, L., & Ricci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 377
Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance
Li, P., Liu, S., Lu, M., Bandyopadhyay, G., Oh, D., Imamura, T., Johnson, A. M. F., Sears, D., Shen, Z., Cui, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.025 · Cited by 297
Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease
Niu, L., Geyer, P. E., Wewer Albrechtsen, N. J., Gluud, L. L., Santos, A., Doll, S., Treit, P. V., Holst, J. J., Knop, F. K., Vilsbøll, T., et al. (2019) · Molecular Systems Biology · doi:10.15252/msb.20188793 · Cited by 285
Shirakawa, K., Endo, J., Kataoka, M., Katsumata, Y., Yoshida, N., Yamamoto, T., Isobe, S., Moriyama, H., Goto, S., Kitakata, H., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035047 · Cited by 252
Coulis, G., Jaime, D., Guerrero-Juarez, C., Kastenschmidt, J. M., Farahat, P. K., Nguyen, Q., Pervolarakis, N., McLinden, K., Thurlow, L., Movahedi, S., et al. (2023) · Science Advances · doi:10.1126/sciadv.add9984 · Cited by 150
Metadata
- Authors
- Li, L.-C., Li, J., & Gao, J.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 351
- Issue
- 2
- Pages
- 336-343
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2123124648
- Cited by
- 261
- References
- 87
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.